Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 8, 2010
Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity
Damir Zadravec, Annelie Brolinson, Rachel M Fisher, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 1, 2007
Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice
Roland Klingenberg, Jerzy-Roch Nofer, Mats Rudling, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 28, 2007
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans
Anders Berkenstam, Jens Kristensen, Karin Mellström, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 20, 2010
Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis
Roland Klingenberg, Michael Lebens, Andreas Hermansson, et al.
Endocrinology
|
April 5, 2008
Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression
Ivan Tancevski, Andreas Wehinger, Egon Demetz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 15, 2008
Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2
Paolo Parini, Ulf Gustafsson, Matt A Davis, et al.
The American Journal of Clinical Nutrition
|
April 12, 2012
Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
Helena Bjermo, David Iggman, Joel Kullberg, et al.
Circulation
|
February 21, 2008
CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice
Peder S Olofsson, Leif A Söderström, Dick Wågsäter, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 2, 2010
Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans
Lena Persson, Guoqing Cao, Lars Ståhle, et al.
Journal of Lipid Research
|
December 25, 2008
The thyromimetic T-0681 protects from atherosclerosis
Ivan Tancevski, Andreas Wehinger, Egon Demetz, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 8, 2010
Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity
Damir Zadravec, Annelie Brolinson, Rachel M Fisher, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 1, 2007
Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice
Roland Klingenberg, Jerzy-Roch Nofer, Mats Rudling, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 28, 2007
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans
Anders Berkenstam, Jens Kristensen, Karin Mellström, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 20, 2010
Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis
Roland Klingenberg, Michael Lebens, Andreas Hermansson, et al.
Endocrinology
|
April 5, 2008
Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression
Ivan Tancevski, Andreas Wehinger, Egon Demetz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 15, 2008
Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2
Paolo Parini, Ulf Gustafsson, Matt A Davis, et al.
The American Journal of Clinical Nutrition
|
April 12, 2012
Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
Helena Bjermo, David Iggman, Joel Kullberg, et al.
Circulation
|
February 21, 2008
CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice
Peder S Olofsson, Leif A Söderström, Dick Wågsäter, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 2, 2010
Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans
Lena Persson, Guoqing Cao, Lars Ståhle, et al.
Journal of Lipid Research
|
December 25, 2008
The thyromimetic T-0681 protects from atherosclerosis
Ivan Tancevski, Andreas Wehinger, Egon Demetz, et al.
Page
of 8